Drawing for FASTPOINT

USPTO serial 79336920

FASTPOINT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
EINSTEIN, MATTHEW T
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with FASTPOINT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
040Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; generation of cell line for the manufacture of biopharmaceutical materials; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicalsACTIVE—
042Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; clinical testing of medicine; pharmaceutical products evaluation; research of medical product; bacteriological research and analysis; medical laboratory services; stem cell research services; conducting clinical trials; medicine research; research and development of technology for biotechnology; microbial culture trials; biochemistry research services; genetic research; scientific research in the field of genetic engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 17, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 17, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 16, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 30, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 30, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 17, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 17, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 17, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 31, 2022RFNTREFUSAL PROCESSED BY IB—
May 6, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2022DOCKASSIGNED TO EXAMINER—
Apr 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 31, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance